• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astal Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4277.0
  • ISIN : INE307N01014
87.53 0 (0.41%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    85.00

  • Today’s High

    89.00

  • Open

    85.00

  • Perv Close

    87.17

  • 52W Low

    66.72

  • 52W High

    131.70

Key Indicators

  • P/E(TTM)

    17.30

  • Mar.Cap (₹Cr.)

    154.40

  • Div & Yield %

    0.00

  • Book Value(₹)

    24.82

  • Debt-Equity Ratio

    0.41

  • AGM Date

    01-Aug-2025

  • EPS

    5.06

  • P/E Ratio

    17.30

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    154.40

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    17.64

  • BV (₹)

    24.80

  • Sales( ₹ in Cr.)

    64.23

  • NP (in Cr.)

    8.93

  • NP Var(%)

    1037.0

  • Div%

    0.0

  • CPS (₹)

    5.20

  • EPS (₹)

    5.10

  • Traded Value (₹ in Lakhs)

    154.40

  • 52 Week High

    131.70

  • 52 Week Low

    66.72

  • Price BSE

    88.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    154.40

  • P/C Ratio

    17.00

  • P/E Ratio

    17.40

  • Price Vs.BV

    5.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 23.65 3.43 0.00 0.20 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 23.65 3.43 0.00 0.20 0.00 0.00
Other Income 0.01 0.18 0.21 0.00 0.20 0.30
Stock Adjustments 1.06 0.00 0.00 0.00 0.00 0.00
Total Income 24.72 3.61 0.21 0.20 0.20 0.30
EXPENDITURE :            
Raw Materials 22.40 3.35 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.02 0.01 0.02 0.01 0.02 0.02
Employee Cost 0.47 0.06 0.09 0.06 0.09 0.07
Other Manufacturing Expenses 0.01 0.01 0.01 0.01 0.01 0.01
Selling and Administration Expenses 0.70 0.13 0.10 0.10 0.10 0.16
Miscellaneous Expenses 0.00 0.00 0.01 0.00 0.00 0.10
Employee Benefit Expenses 0.47 0.06 0.09 0.06 0.09 0.07
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 23.59 3.56 0.21 0.18 0.22 0.36
Operating Profit 1.13 0.04 0.00 0.02 -0.01 -0.06
Interest 0.01 0.00 0.00 0.00 0.00 0.00
Gross Profit 1.12 0.04 0.00 0.02 -0.01 -0.06
Depreciation 0.03 0.01 0.01 0.02 0.02 0.02
Profit Before Tax 1.09 0.03 -0.01 0.00 -0.03 -0.08
Current Tax 0.29 0.01 0.00 0.00 0.00 0.01
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.01 0.01 0.00 0.00 0.00 0.00
Reported Net Profit 0.78 0.02 -0.02 0.01 -0.03 -0.08
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.78 0.02 -0.02 0.01 -0.03 -0.08
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.99 0.98 0.99 0.99 1.02 1.10
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 1.78 0.99 0.98 0.99 0.99 1.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.80 0.04 -0.04 0.02 -0.07 0.00
Earnings Per Share(Adj)-Unit Curr 0.80 0.04 -0.04 0.02 - -
Book Value 23.71 12.98 12.93 12.97 12.96 13.03
Book Value(Adj)-Unit Curr 23.71 12.98 12.93 12.97 - -

Shareholding Pattern

  • Promoter Group

    19.93%

  • Public Share Holding

    80.07%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 1,959,284 19.93 1,959,284 1
Sub Total 1,959,284 19.93 1,959,284 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 548,351 5.58 511,151 31
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 20,297 0.21 20,297 14
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 85,255 0.87 85,255 39
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,103,637 51.92 5,103,637 71
Individuals holding nominal share capital up to Rs. 1 lakh 2,113,246 21.50 1,732,626 2,565
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,870,786 80.07 7,452,966 2,720
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,830,070 100.00 9,412,250 2,721

Company Background

Astal Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Astal Laboratories Ltd
  • BSE Code : 4277.0
  • ISIN : INE307N01014

  • Incorporation Year

    1993

  • Registered Office

    House No 4-50/1 Sy No 134 132
    Block B 8th Floor Flat No 801, Hyderabad,
    Telangana-500032

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    MAHENDRA KUMAR

  • Auditor

    Sathuluri & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.&Computer Ser.P Ltd
    Beetal House 3rd Flr,
    Behind Local Shp Cen,Nr Dada Harsukh Das
    Mumbai - New Delhi - 110062

Astal Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astal Lab 87.53 23.66 23.65 17.30 7.56
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10